Expressions of G9a and H3K9me2 are positively associated with a higher WHO glioma grade and the G9a inhibitor BIX-01294 inhibits proliferation, induces apoptosis, and reduces mono- and dimethylation of H3K9 in U251 human GBM cells [39]. This evidence concerns the gene EHMT2 and central nervous system cancer.